Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuropharmacology|September 28, 2011
The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levelsJulie Espallergues, Takayoshi Mamiya, Monique Vallée, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Induction of antigen-specific CTL responses using antigens conjugated to short peptide vectorsFiona H Day, Yu Zhang, Philippe Clair, et al.The Journal of Pharmacology and Experimental Therapeutics|January 14, 2005
Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide vector-mediated strategyJamal Temsamani, Cécile Bonnafous, Christophe Rousselle, et al.The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategyChristophe Rousselle, Philippe Clair, Maria Smirnova, et al.Pharmaceutics|April 27, 2024
LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In VivoBaptiste Broc, Karine Varini, Rose Sonnette, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 22, 2017
Use of LDL receptor-targeting peptide vectors for <i>in vitro</i> and <i>in vivo</i> cargo transport across the blood-brain barrierYves Molino, Marion David, Karine Varini, et al.Brain Research|April 17, 2007
A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transportersNicolas Perrière, Salah Yousif, Sylvie Cazaubon, et al.Communications Biology|August 20, 2021
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinomaAngélina Acier, Magali Godard, Fanny Gassiot, et al.Elife|March 28, 2025
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in miceLotfi Ferhat, Rabia Soussi, Maxime Masse, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2025
Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous systemMarion David, Romy Cohen, Diane Beuzelin, et al.Pageof 2